AOP Orphan Pharmaceuticals AG   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Vienna Austria (1996)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2000
NCT02533895
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Activartis Biotech | AOP Contract Clinical Research Facility